SCHEMBL4160723

SCHEMBL4160723

O=C(Cc1ccccc1)NC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MME P08473 3/20 0.63
CHRNA1 P02708 3/20 0.62
CHRNG P07510 3/20 0.62
CHRNB1 P11230 3/20 0.62
CHRND Q07001 3/20 0.62
ITGB3 P05106 1/20 0.62
ITGA2B P08514 1/20 0.62
GRIA1 P42261 1/20 0.59
ACE P12821 6/20 0.59
CTSL P07711 1/20 0.57
CTSB P07858 1/20 0.57
CTSS P25774 1/20 0.57
FOLH1 Q04609 1/20 0.56
NAALAD2 Q9Y3Q0 1/20 0.56
GPR34 Q9UPC5 1/20 0.55
CPA1 P15085 1/20 0.54
ACE2 Q9BYF1 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4162326 1.00 MME (0.63) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL4160727 1.00 MME (0.63) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL27840664 1.00 MME (0.63) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL4162323 1.00 MME (0.63) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL4161387 0.95 ACE (0.62) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL4161392 0.95 ACE (0.62) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL28522339 0.93 CHRNA1 (0.60) MMECHRNA1CHRNGCHRNB1CHRND
SCHEMBL10504767 0.92 ITGB3 (0.65) MMEITGB3ITGA2BACECTSL
SCHEMBL4144665 0.92 ITGB3 (0.65) MMEITGB3ITGA2BACECTSL
SCHEMBL4144668 0.92 ITGB3 (0.65) MMEITGB3ITGA2BACECTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109182200-B Lysinibacillus fusiformis ZJB-17006 and application thereof 浙江工业大学 2020-10-09 CN claimed
CN-109321493-B B-lysine-resistant bacillus ZJB-17007 and application thereof 浙江工业大学 2020-10-02 CN claimed
CN-109321490-B Enterobacter aerogenes ZJB-17003 and application thereof 浙江工业大学 2020-08-21 CN claimed
CN-109321491-B Xiangfang enterobacter ZJB-17001 and application thereof 浙江工业大学 2020-08-21 CN claimed
CN-109321492-B Non-decarboxylation lechler bacterium ZJB-17008 and application thereof 浙江工业大学 2020-08-21 CN claimed
CN-109321495-B Clinkerwell ZJB-17005 and application thereof 浙江工业大学 2020-08-21 CN claimed
CN-109321497-B Lysine-elongated bacillus ZJB-17009 and application thereof 浙江工业大学 2020-07-28 CN claimed
CN-109321494-B Kluyveromyces intermedia ZJB-17004 and application thereof 浙江工业大学 2020-06-23 CN claimed
CN-109321496-B Citrobacter freundii ZJB-17010 and application thereof 浙江工业大学 2020-06-23 CN claimed
CN-109182201-B Enterobacter hesheng biological I type ZJB-17002 and application thereof 浙江工业大学 2020-06-23 CN claimed
CN-109321492-A Leclercia adecarboxylata ZJB-17008 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109321497-A Long lysine bacillus ZJB-17009 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109321495-A Kluyvera cryocrescens ZJB-17005 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109321496-A Citrobacter freundii ZJB-17010 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109321493-A The lysine of resistance to boron bacillus ZJB-17007 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109321491-A Xiangfang enterobacteria ZJB-17001 and its application 浙江工业大学 2019-02-12 CN claimed
CN-109182201-A Enterobacter amnigenus I type ZJB-17002 of biology and its application 浙江工业大学 2019-01-11 CN claimed
CN-109182200-A Spindle lysine bacillus ZJB-17006 and its application 浙江工业大学 2019-01-11 CN claimed
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) 2009-04-30 US claimed
EP-1876169-A1 PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) 2008-01-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090111874-A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof PAH, MAOA, APEH MME 634/4885CHRNA1 530/4885CHRNG 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.